Q2 2020 Holdings
Filed 2020-08-13 | 235 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $238.5M | 1,610,065 | 20.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $215.2M | 4,023,573 | 18.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $214.9M | 954,016 | 18.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $66.3M | 1,042,747 | 5.8% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $63.8M | 365,833 | 5.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $60.8M | 1,730,620 | 5.3% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $59.2M | 1,403,000 | 5.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $53.1M | 1,581,703 | 4.6% |
| Caredx Inc(CDNA) | COM | 14167L103 | $41.3M | 1,166,839 | 3.6% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $36.1M | 79,871 | 3.2% |
| Align Technology Inc(ALGN) | COM | 016255101 | $27.1M | 98,869 | 2.4% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $20.7M | 1,157,400 | 1.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $10.9M | 58,000 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.5M | 76,900 | 0.8% |
| Avantor Inc(AVTR) | COM | 05352A100 | $6.2M | 364,877 | 0.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.6M | 37,000 | 0.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $3.3M | 50,000 | 0.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.2M | 44,900 | 0.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.0M | 13,300 | 0.2% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $1.5M | 83,500 | 0.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $486.4K | 8,249,873 | 0.0% |
| Adobe Inc(ADBE) | COM | 00724F101 | $479.0K | 1,100 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $391.7K | 3,210,900 | 0.0% |
| Constellation Brands Inc(STZ) | CL A | 21036P108 | $360.0K | 2,059 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $342.3K | 3,292,600 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $285.3K | 982,600 | 0.0% |
| Esperion Therapeutics Inc New(ESPR) | COM | 29664W105 | $272.1K | 5,303,135 | 0.0% |
| Blackbaud Inc(BLKB) | COM | 09227Q100 | $234.0K | 4,107 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $214.8K | 3,344,950 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $180.4K | 6,730,552 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $158.6K | 1,412,828 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $139.7K | 5,002,116 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $117.4K | 1,284,272 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $116.7K | 1,208,313 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $97.0K | 3,779,919 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $95.8K | 4,647,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $95.5K | 7,007,385 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $94.8K | 1,612,112 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $91.4K | 235,640 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $90.4K | 306,636 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $89.6K | 977,523 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $89.0K | 156,233 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $81.9K | 3,535,013 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $81.5K | 310,025 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $79.9K | 451,633 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $72.3K | 3,047,500 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $67.3K | 1,961,400 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $63.2K | 336,726 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $58.9K | 1,415,504 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $58.8K | 245,940 | 0.0% |